Theravance Biopharma, Inc. — SC 13G/A Filings
60 SC 13G/A filings on record
This page lists all SC 13G/A filings submitted to the SEC by Theravance Biopharma, Inc. (TBPH), sorted by most recent first. Each row links to the full filing on EdgarLookup. Theravance Biopharma, Inc. has filed 60 SC 13G/A documents with the SEC since 2015. To view all SEC filings by Theravance Biopharma, Inc., see the full filings list.
All
10-12B
10-12B/A
10-K
10-Q
10-Q/A
144
3
3/A
4
4/A
424B5
8-A12B
8-K
8-K/A
CERTNAS
CORRESP
CT ORDER
DEF 14A
DEFA14A
EFFECT
FWP
PRE 14A
S-3
S-3/A
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-C
SC TO-I
SC TO-I/A
SCHEDULE 13D/A
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13G/A | AMENDMENT NO. 3 TO SCHEDULE 13G | 0001213900-17-001381 | Feb 14, 2017 | — |
| SC 13G/A | NONE | 0001140361-17-007331 | Feb 14, 2017 | — |
| SC 13G/A | — | 0000315066-17-002106 | Feb 14, 2017 | — |
| SC 13G/A | AMENDMENT NO. 2 TO SCHEDULE 13G | 0001213900-17-001380 | Feb 14, 2017 | — |
| SC 13G/A | — | 0000215457-17-001769 | Jan 27, 2017 | — |
| SC 13G/A | AMENDMENT NO. 2 SCHEDULE 13G | 0001213900-16-015549 | Aug 4, 2016 | — |
| SC 13G/A | AMENDED SCHEDULE 13G | 0001213900-16-011087 | Feb 19, 2016 | — |
| SC 13G/A | AMENDED SCHEDULE 13G | 0001213900-16-011085 | Feb 19, 2016 | — |
| SC 13G/A | NONE | 0001140361-16-052319 | Feb 12, 2016 | — |
| SC 13G/A | — | 0000215457-16-004057 | Jan 27, 2016 | — |